TSPO and Stroke: Studies performed with the reference TSPO radioligand 11C-PK11195 in stroke patients indicated that the binding became significant a few days after the stroke onset, subsequently increased in approximately 1 week, and declined after 3 to 4 weeks [18,19,29].